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Active time as measured by an internal pacemaker accelerometer
predicts reduced survival (p < 0.001 by log rank test).There is growing recognition that physical inactivity
in the general population is an important risk factor
for cardiovascular disease and death (1–3). To date,
there are limited data as to the predictive value of
physical activity in individuals with pacemakers and
preserved left ventricular (LV) function. Implanted
cardiac pacemakers provide a unique opportunity to
collect precise quantitative longitudinal data with
respect to physical activity level in this at-risk
population.
We retrospectively reviewed records of in-
dividuals who underwent de novo implantation of a
Medtronic EnRhythm or Revo device (Medtronic,
Minneapolis, Minnesota) between January 1, 2005,
and December 31, 2012, at 1 academic medical center.
Physical activity proﬁles were obtained from routine
interrogation data downloaded at 3-month intervals
and averaged over a 1-year time period following a
6-month post-implantation blanking period. We
divided subjects qualifying for study inclusion into 4
activity categories: <1 h/day, 1 to <2 h/day, 2 to
<3 h/day, and >3 h/day (reference category).
A total of 149 subjects were screened, and 53 sub-
jects were excluded due to their procedure being a
generator change rather than a new implant, or
incomplete follow-up. Subjects were divided into 4
groups based on average active minutes and followed
for an average of 4.1  2.2 years after pacemaker
implant. There were a total of 18 deaths during the
follow-up period.
All-cause mortality signiﬁcantly increased as active
minutes decreased (7%, 9%, 29%, and 42% all-cause
mortality in order from highest to lowest active
minute category; p ¼ 0.004). Kaplan-Meier analysis
demonstrated total mortality was signiﬁcantly higher
as pacemaker-quantiﬁed active minutes decreased
(Figure 1). In age- and sex-adjusted analyses, patients
with an average of <1 h/day of active time had a
nearly 7.5-fold increased risk of death during follow
up compared to those who were active >3 h/day (odds
ratio [OR]: 7.44; 95% conﬁdence interval [CI]: 1.88 to29.43; p ¼ 0.007). Patients who averaged 1 to 2 h/day
of active time had nearly 3.5 times the risk of death
compared to the reference group, but this OR fell
short of statistical signiﬁcance (OR: 3.47; 95% CI:
0.84 to 14.39; p ¼ 0.09). No signiﬁcant increase in the
risk of death was seen comparing those who
completed 2 to 3 h/day of active time versus the
reference group (OR: 1.06; 95% CI: 0.11 to 10.22;
p ¼ 0.96).
The use of implantable cardiac devices to assess an
individual’s activity level has unique advantages. It
represents an objective measurement of movement
and removes recall bias and inaccuracies. Further-
more, as patients with pacemakers are typically fol-
lowed on a quarterly basis, regular follow-up, and
access to activity data is easily obtainable.
Two prior studies using accelerometer data from
implanted cardiac devices found a correlation be-
tween survival and physical activity as measured by
accelerometers in patients with impaired LV ejection
fractions (4,5). Our data signiﬁcantly extend these
ﬁndings to a population without a reduction in
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755LV ejection fraction, which in itself may be related
to reduced activity levels. Further, our data ac-
count for activity levels well outside the peri-
implantation window, which mitigates the impact of
periprocedural complications on the relationship be-
tween activity time and mortality.
Our study is limited by the relatively small study
population. We did not include other pacing devices
with accelerometers as their algorithms for deter-
mining active time may differ from the 2 devices
included in this study. We elected not to include pa-
tients with deﬁbrillators so as to reduce the con-
founding effects of impaired cardiac function on
activity levels. Balanced against these limitations are
the quantitative nature of our data, the novelty of the
ﬁndings and their potential impact on the care of
patients post-pacemaker implantation.
Physical activity as measured by an implanted
accelerometer is correlated with mortality—those who
are less active have decreased survival independent
of other risk factors. Our ﬁndings support the notion
that care providers following patients with pace-
makers could use these readily available data for risk
stratiﬁcation, to encourage increased physical activ-
ity, and to follow patient compliance with physical
activity recommendations. Whether interventions to
decrease inactive time can impact survival needs to
be prospectively studied.Sudhi Tyagi, MD
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Syndrome as a Predictor
of Cardiovascular Disease
Between Childhood
and Adulthood
The Princeton Lipid Research Cohort StudyThe long-term ability of the metabolic syndrome
(MetS) to predict cardiovascular disease (CVD) has
been limited by the binary nature of traditional
MetS criteria and by discrepancies among African
Americans, who have low rates of MetS classiﬁcation
despite higher rates of death from CVD (1). We pre-
viously used conﬁrmatory factor analysis to formu-
late MetS severity z-scores for adolescents (2) and
adults (3) that place differential weights on the indi-
vidual MetS components to account for variation in
how MetS is manifest by sex and racial/ethnic group.
Our goal was to assess the ability of these scores to
determine long-term risk for CVD.
The Princeton Lipid Research Cohort Study fol-
lowed white and black (30.5%) individuals (55.5%
female) over 3 phases: 1) the LRC (Lipid Research
Clinic) (1973 to 1976) evaluated MetS measures on
students in grades 1 to 12 (4); 2) the PFS (Princeton
Follow-Up Study) (1998 to 2003) evaluated complete
MetS measures and reported CVD status on 629 LRC
participants (4); and 3) the PHU (Princeton Health
Update) (2010 to 2014) assessed CVD outcomes via
phone interviews and National Death Index query
on 354 cohort members. CVD was classiﬁed as self-
reported myocardial infarction, coronary artery
bypass, other heart surgery, coronary revasculariza-
tion procedure (angioplasty, stent placement), or
stroke. MetS severity z-scores were calculated from
each individual’s measures of body mass index
z-score (children/adolescents) or waist circumference
(adults), systolic blood pressure, fasting triglycerides,
and fasting glucose, based on equations speciﬁc to
sex and racial/ethnic subgroup from LRC and PFS
visits. Mean MetS z-scores were compared based on
